Plosaracetam

N/A

Report date: 2025/05/26 16:59:21
NME

Base Information

Drug NamePlosaracetam
Drug Alias NameSDI-118ABBV-552
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSynaptic vesicle glycoprotein 2A agonists
TargetsSynaptic vesicle glycoprotein 2A
Therapy Area/IndicationsCognition DisordersDepressive DisorderAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNew Zealand +[8
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUcb Biopharma Srl
China Registration ClassN/A

Develop Information

Active CompaniesAbbvie Inc
Inactive CompaniesSyndesi Therapeutics SA
Active IndicationsAlzheimer Disease
Inactive IndicationsCognition DisordersDepressive Disorder

Other Information

ATC CodeN/A
Related LinksN/A